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fenestral diaphragms and 
pLVAp associations in liver 
sinusoidal endothelial cells are 
developmentally regulated
Kaisa Auvinen1,2, Emmi Lokka1,2,4, Elias Mokkala1,2,4, Norma Jäppinen1,2, Sofia tyystjärvi1,2, 
Heikki Saine1,2, Markus peurla2, Shishir Shetty3, Kati elima1,2, Pia Rantakari  1,2 & 
Marko Salmi1,2*
Endothelial cells contain several nanoscale domains such as caveolae, fenestrations and 
transendothelial channels, which regulate signaling and transendothelial permeability. These structures 
can be covered by filter-like diaphragms. A transmembrane PLVAP (plasmalemma vesicle associated 
protein) protein has been shown to be necessary for the formation of diaphragms. The expression, 
subcellular localization and fenestra-forming role of PLVAP in liver sinusoidal endothelial cells (LSEC) 
have remained controversial. Here we show that fenestrations in LSEC contain PLVAP-diaphragms 
during the fetal angiogenesis, but they lose the diaphragms at birth. Although it is thought that PLVAP 
only localizes to diaphragms, we found luminal localization of PLVAP in adult LSEC using several 
imaging techniques. Plvap-deficient mice revealed that the absence of PLVAP and diaphragms did 
not affect the morphology, the number of fenestrations or the overall vascular architecture in the liver 
sinusoids. Nevertheless, PLVAP in fetal LSEC (fenestrations with diaphragms) associated with LYVE-1 
(lymphatic vessel endothelial hyaluronan receptor 1), neuropilin-1 and VEGFR2 (vascular endothelial 
growth factor receptor 2), whereas in the adult LSEC (fenestrations without diaphragms) these 
complexes disappeared. Collectively, our data show that PLVAP can be expressed on endothelial cells 
without diaphragms, contradict the prevailing concept that biogenesis of fenestrae would be PLVAP-
dependent, and reveal previously unknown PLVAP-dependent molecular complexes in LSEC during 
angiogenesis.
Vascular endothelium is a critical gate-keeper between the circulation and different tissue environments. Under 
normal conditions it regulates the development, homeostasis and metabolism of tissues, and under pathological 
conditions it is heavily involved in inflammation and tumorigenesis1–3. Heterogeneity of vascular endothelium 
has been recognized for decades4. The endothelial cells (EC) are divided to continuous, fenestrated and sinusoi-
dal based on their subcellular morphology4,5. Continuous EC, the most common endothelial type, are barrier 
forming cells, which allow diffusion of water and small solutes to the extravascular compartment without loss of 
plasma proteins or blood cells. The barrier function of EC is particularly pronounced in some highly specialized 
vascular beds, like at the blood-brain barrier. Fenestrated EC, on the other hand, have intracellular openings, 
which penetrate the whole thickness of the cell. These fenestrae (open pores, “windows”) are usually covered 
by a thin proteinaceous diaphragm. This capillary type is characteristic to specific organs, like kidney, several 
endocrine organs and choroid plexus, which display increased permeability. Finally, the sinusoidal discontinuous 
endothelium is found in liver, spleen and bone marrow. Larger fenestrations, incomplete basement membrane, 
and possibly interendothelial gaps, specify this EC type.
The only known protein component in the diaphragms covering the endothelial fenestrations is PLVAP6–10. This 
protein, also known as PV-1, PAL-E and MECA-32 antigen, is a type 2 transmembrane glycoprotein, which forms 
rod-like homodimeric fibrils that are thought to radiate from the rim of the fenestration towards a central knob7,11. 
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When analyzed from kidney and pancreas EC, the diaphragms displayed a cart-wheel like structures, which 
typically show a 50–70 nm diameter, although the range of diaphragms varied from <50 nm to >93 nm, and the 
size distribution was partially affected by tissue fixation methods used12. PLVAP-diaphragms also guard transen-
dothelial channels both at the luminal and abluminal aspects of the EC6. In addition PLVAP-diaphragms are 
present on a subset of caveolae, which are flask-shaped invaginations of the plasma membrane serving multiple 
endocytic and signaling functions6,13. Notably, according to the current dogma, PLVAP is thought to be present 
only in diaphragms7–9.
The physiological functions of PLVAP have been analyzed in three independently generated Plvap−/− mouse 
lines8,9,14. The absence of PLVAP results in high embryonic lethality with only low numbers of surviving pups 
in mixed backgrounds. The newborns are growth retarded and survive only about 5–6 wk. In all three mouse 
lines, deletion of PLVAP results in loss of all identifiable diaphragms. While PLVAP is necessary for diaphragm 
formation, it is not sufficient for it. This was shown in elegant experiments by Stan et al. showing that forced 
pan-endothelial PLVAP expression in Plvap−/− mice did not result in diaphragm formation in those vascular 
beds in which PLVAP is not normally expressed8. Plvap−/− mice manifest with increased vascular permeability 
resulting in leakage of intravascular proteins smaller than 70 kDa out from the vasculature8. Plvap−/− mice are 
thought to succumb due to protein losing enteropathy8, and a similar fatal outcome has been reported in  four 
human patients lacking intact PLVAP15–17. In addition, in mice PLVAP regulates the permeability of subcapsular 
sinus lymphatic endothelial cells to leukocytes and antigens in peripheral lymph nodes14, and the generation of 
fetal-derived macrophages in the fetal liver18.
Contradicting reports have been published regarding PLVAP expression and functions in the liver8,11,19–24. The 
liver vasculature has a complex architecture5,25. Oxygenated blood from the hepatic artery and intestine-draining 
blood from the portal vein enter the liver within the portal tracts, mix in the liver sinusoids percolating between 
the hepatocyte cords, and leave the organ via central venules and finally via the hepatic vein. Liver sinusoids 
show zonation along the portal to central vein axis, which also reflected in the phenotype of liver sinusoidal 
endothelial cells (LSEC)26–29. Characteristic to LSEC are numerous fenestrations, which are largely concentrated 
to sieve plates30–33. The fenestrations (open pores, “windows”) have a mean diameter of ~150–175 μm (range 
~75–300 μm) in rat LSEC when measured by transmission electron microscopy, but the reported dimensions vary 
depending on the species, age, sinusoidal zonation and method of analyses29–31,34,35. The density of fenestrations 
also differs in the different sinusoidal zones29,35. The fenestrations allow free contacts between small blood compo-
nents (e.g. chylomicron remnants), and hepatocytes and stellate cells through the narrow space of Disse31,32. Early 
electron microscopy studies have shown the presence of diaphragms in fetal rat sinusoids36,37 and the lack of dia-
phragms in the adult sinusoids29,30,34,35. LSEC also express caveolin-1, an essential component of caveola38. A very 
high endocytic capacity is another typical feature of LSEC.30–33. In fact, LSEC show a clear division of work with 
macrophages in actively scavenging blood-borne macromolecular waste molecules and immune complexes39,40.
Consistent with the lack of diaphragms in the adult liver LSEC.31–33,35, many studies have reported that PLVAP 
is absent from normal LSEC.19–22. However, others have found variable PLVAP protein or mRNA expression in 
the adult liver7,23,24 and it has been claimed that PLVAP is actually needed for the fenestral biogenesis24. Therefore, 
our aim was to explore the synthesis of PLVAP, diaphragms and fenestrations in the different EC compartments 
(arterial, portal vein, sinusoidal and central vein) of liver, analyze PLVAP associations in LSEC and re-examine 
the functional role of PLVAP in fenestral biogenesis in vivo. Using multimodal imaging and PLVAP-deficient 
mice we show that while not necessary for fenestral biogenesis, PLVAP forms diaphragms and is associated with 
angiogenic signaling complexes during fetal liver angiogenesis, whereas in adult LSEC it displays a conceptually 
novel extra-diaphragmatic localization.
Results
Prenatal LSEC have PLVAP-diaphragms in fenestrae. Since there are discrepant reports regarding 
the expression of PLVAP protein in liver8,11,19–24, we used timed matings to get fetal and postnatal liver speci-
mens from wild-type mice (here all wild-type mice refer to littermate controls of Plvap−/− mice, unless otherwise 
stated) for re-evaluating the expression of PLVAP in LSEC during liver angiogenesis. Using an anti-PLVAP mAb 
MECA-32 and confocal microscopy analyses we found that PLVAP was expressed in virtually all LSEC (defined 
by LYVE-1 expression31,41,42) before birth (Fig. 1a). Clear PLVAP-positivity in LYVE-1+ LSEC was also found in 
new-born mice, as well as at later postnatal time points (Fig. 1a,b). No apparent PLVAP expression was found in 
non-vascular cell types in liver at any developmental stage studied. In addition to these hybrid littermate wild-
types, PLVAP protein in LSEC was found also in all other mouse strains studied (Balb/c, C57BL6J, and C57BL6N; 
Suppl. Figure 1a,b).
Consistent with PLVAP mRNA analyses in adult mouse liver8,23,24, our immunoblotting analyses confirmed 
that PLVAP protein was present in adult liver lysates and revealed that it migrated as a ~120 kDa band consistent 
with a homodimeric nature of the molecule (Fig. 1c). The quantifications of PLVAP/GAPDH ratios implied that 
relatively more PLVAP may be present in liver at E14.5 embryos than in adults (Fig. 1c), with the caveat that the 
identification of a stable loading control protein in a developing complex organ is inherently challenging. The 
specificity of the MECA-32 antibody was confirmed by the lack of reactivity with liver lysates of Plvap−/− mice. 
Thus, PLVAP protein is expressed in the liver throughout the development, and it localizes to vessels.
In line with earlier reports in rats and mice24,36,37, we found typical cross-sectional profiles of protein dia-
phragms overlaying LSEC fenestrations throughout the embryonic development (E12.5-E18.5) (Fig. 1d). Electron 
tomography showed that the diaphragms in the fetal LSEC displayed the characteristic radial fibrils spanning 
from the fenestral rim towards a central density (Fig. 1e). Notably, after birth (postnatal day 0.5, and 5 wk, 9 wk 
and 28 wk old mice), no identifiable diaphragms were observed any more in the sinusoidal fenestrations (Fig. 1d), 
as previously reported by others29,30,34,35.
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Figure 1. Fenestral diaphragms and PLVAP expression in LSEC during liver ontogeny. (a,b) Confocal 
microscopy analyses of PLVAP and LYVE-1 expression in LSEC during the fetal (E12.5-E18.5) and postnatal 
(newborn-11 wk) development. Bars, 50 µm (main figures) and 10 µm (insets). (c) Immunoblot analyses of 
fetal and adult liver lysates (5 µg protein/lane) from wild-type (wt) and Plvap−/− mice for PLVAP and GAPDH 
(a house keeping molecule) under non-reducing conditions. The same filter was sequentially probed for 
PLVAP and GAPDH. Full blots are shown in Suppl. Figure 10. (d) Transmission electron micrographs from 
LSEC fenestra in fetal and postnatal liver at the indicated ages. Red arrows, diaphragms; red arrowheads, 
open fenestra. Bars, 40 nm. (e) Electron tomography of a diaphragm in E14.5 fetal liver of wild-type mice. 
Perpendicular view of the boxed area is shown at a higher magnification in the inset. Bars, 200 nm (inset 20 nm). 
Shown are representative images (numbers of mice/genotype: n = 3 (a,b), n = 1 (E16.5, 9 wk, 28 wk in d,e), 
n = 2 (E14.5 wild-type in c, and E12.5 in d), n = 3–4 (E14.5, E18.5, new-born, 2 wk and 5 wk in d), n = 4 (adult 
wild-type, and E14.5 and adult Plvap−/− in c).
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Our electron microscopy data is in line with the prevailing concept that the adult sinusoidal vasculature 
in liver contains open fenestrations, but that LSEC fenestrations are guarded by diaphragms until the birth. 
Collectively, our data show that PLVAP protein in the LSEC is induced early on, expressed throughout the liver 
angiogenesis and maintained in the adulthood.
Non-diaphragmal PLVAP in adult LSEC. To address the unexpected finding of PLVAP expression in 
the absence of fenestral diaphragms in adult LSEC, we further analyzed the relation of diaphragms and PLVAP 
in the liver vasculature. Electron microscopy showed that diaphragms were indeed still present in larger veins 
of adult liver in wild-type mice. These vein EC, underlined by a well-developed basement membrane, displayed 
typical caveolae, fenestrations and transendothelial channels, all of which had clear diaphragms (Fig. 2a, Suppl. 
Figure 1c). In 5 wk old Plvap−/− mice, the vein EC also contained uncoated endocytic carriers (possibly caveolae) 
and fenestrations or transendothelial channels, but they lacked all diaphragms (Suppl. Figure 1d,e).
In confocal microscopy analyses of the vascular segments in adult liver, the portal and central vein EC were 
PLVAP bright, whereas no signal compatible with the PLVAP expression in the hepatic artery was detectable 
(Fig. 2b). The identity of these non-sinusoidal vessels was confirmed in additional experiments by histology 
(hematoxylin-eosin stainings) and by including CD31 as a pan-endothelial cell marker. These stainings and their 
quantification confirmed PLVAP-negativity of the hepatic artery (Suppl Figure 2a–c). We found that the LSEC in 
the periportal, pericentral segments, and mid-lobular sinusoid segments all expressed PLVAP (Fig. 2b,c). When 
quantified, the PLVAP expression level was lower at all sinusoidal locations when compared to the portal vein 
(Fig. 2d, Suppl. Figure 2d). Notably, some LSEC, which were LYVE-1neg/low, were clearly PLVAP+ (Fig. 2e,f). The 
LYVE-1neg/lowPLVAP+ vessels also expressed CD144 (VE-cadherin) and CD31 (Fig. 2e,f, and Suppl. Figure 2e,f), 
confirming their vascular identity. Our observations of strong PLVAP expression in the venular EC are in line 
with our electron micrographs revealing the presence of diaphragmed caveolae, fenestrations and transendothe-
lial channels in these vessels. However, the stainings also showed definitive PLVAP expression in the majority of 
LSEC in adults.
LSEC are reported to contain low levels of caveolae38, which can be overlaid by PLVAP-diaphragms in other 
organs6. To study the potential role of caveolae in conferring PLVAP-positivity to the sinusoidal segments of adult 
liver vasculature we used Caveolin-1(Cav-1)-deficient mice, which lack all caveolae43. Using immunoblotting, 
a clear PLVAP signal was evident from the liver lysates of Cav1−/− mice (Fig. 3a). Confocal microscopy further 
showed that in the absence of caveolae PLVAP was still expressed in the liver sinusoids (Fig. 3b, Suppl. Figure 3a–
c). Thus, caveolae and their diaphragms in LSEC have minimal, if any, contribution to the PLVAP-positivity of 
adult LSEC.
To interrogate the possibility that PLVAP protein in adult LSEC would present a carry-over from the fetal 
period, we analyzed its persistence in old mice and evaluated Plvap mRNA synthesis in different EC popula-
tions in adult liver. We found clear PLVAP positivity in LSEC of 24 wk old wild-type mice (Fig. 3c and Suppl. 
Figure 3d,e), which argues against the carry-over effect. We then sorted sinusoidal and non-sinusoidal blood 
vascular EC44 from livers of 5 wk old wild-type mice. CD45 and podoplanin were used to exclude leukocytes and 
lymphatic EC, respectively. CD144+ EC were then divided into LYVE1+ sinusoidal and LYVE1− non-sinusoidal 
(venular and arterial EC). As expected, Lyve-1 mRNA was present only in the sinusoidal EC compartment, and 
not in the large vessel EC or in an irrelevant control cell type (leukocytes) (Fig. 3d) verifying the purity of the 
sorted EC populations. Analyzing these cell populations for Plvap mRNA, we found robust and specific synthesis 
both in the large vessel and sinusoidal EC in the adult liver (Fig. 3d). Collectively these data show that adult LSEC 
synthesize Plvap mRNA and express PLVAP protein in non-caveolar structures.
Cell surface expression of PLVAP in adult LSEC. To analyze if the PLVAP protein in the absence of 
diaphragms would be mistargeted to intracellular compartments in the adult LSEC (similar to CD3145), we per-
formed in vivo labelings of the liver vasculature. When the anti-PLVAP antibody (MECA-32) was administered 
intravenously to wild-type mice, a specific signal was recovered 10 min later from the LYVE1+ LSEC (Fig. 4a). 
Similar MECA-32 injections into the Plvap-deficient mice gave no signal in LSEC or in any other cell type verify-
ing the specificity of the approach (Fig. 4a).
We then used immunoelectron microscopy to visualize PLVAP localization in adult LSEC. The results were 
compatible with the possibility that PLVAP is expressed on the luminal plasma membrane of sinusoidal vessels 
(Fig. 4b and Suppl. Figure 4a). PLVAP signal was detected both from the membrane areas juxtapositioned to the 
fenestral pores and from the plasma membrane area that was apparently separated from the fenestrations. No 
PLVAP-signal was detected in non-EC types, and an isotype matched control antibody gave no signal in fenes-
tral or non-fenestral area of EC or in any other cell type (Fig. 4c and Suppl. Figure 4a,b). Moreover, after in vivo 
injection of gold-labelled MECA-32 antibody, the gold nanoparticles were found on the sinusoidal EC membrane 
(Suppl. Figure 4c). Within the technical limitations of the assays (e.g. possible internalization of the circulating 
MECA-32 antibody, resolution limits of the two-stage gold labeling technique, physicochemical properties of the 
directly gold-labeled MECA-32 antibody) these analyses suggest that despite the absence of fenestral diaphragms 
in adult liver sinusoids, PLVAP protein is present on the surface of LSEC.
PLVAP is not needed for the formation of fenestrations or sinusoids in the liver. Since fetal LSEC 
fenestrations were covered by diaphragms and since the generation of fenestrae in liver has been reported to be 
PLVAP-dependent24, we visualized fenestrations by scanning electron microscopy. In adult wild-type mice LSEC 
fenestrations grouped into the typical sieve plates (Fig. 5a). In Plvap−/− mice fenestrations (or transendothelial 
channels, which cannot be separated from fenestrations in the absence of diaphragms) were also readily detect-
able (Fig. 5a). Based on the quantifications of the areas covered by sieve plates, the numbers of fenestrations 
within the sieve plates, the number of fenestrae/ µm2 endothelial surface area and the average size of fenestral 
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Figure 2. PLVAP expression in the diaphragmed and non-diaphragmed domains of endothelial cells in adult 
liver. (a) Transmission electron micrographs from a vein in liver of a 9 wk old wild-type mouse. VL, vascular 
lumen, BM, basement membrane (yellow dotted line). The two boxed areas are shown at a higher magnification 
in the insets. Red arrows, diaphragms in caveolae, fenestrae, and transendothelial channels. Bar, 40 nm.  
(b) Confocal microscopy analyses of PLVAP and LYVE-1 expression in 5 wk old wild-type mice. Blue is DAPI. 
CV, central venule; PV, portal venule. Bar, 100 µm. (c) Higher magnifications of the areas defined by the green 
boxes in (b) Bar, 10 µm. (d) Quantification of relative PLVAP staining intensities (mean ± s.e.m, n = 4 mice) 
from the portal vein, periportal, midlobular and pericentral sinusoids and from the central vein. Intensity 
value 1.0 was assigned to the portal vein in each animal. (e,f) Confocal microscopy analyses of PLVAP, LYVE-1 
and CD144 (e) and PLVAP, LYVE-1 and CD31 (f) expression in 5 wk old wild-type mice. White arrowheads 
point to LYVE-1−PLVAP+CD144+ (e) and LYVE-1−PLVAP+CD31+ (f) sinusoids. Red arrowheads point to 
LYVE-1+PLVAP+CD144+ (e) and LYVE-1+PLVAP+CD31+ sinusoids (f). Bars, 50 µm. Shown are representative 
images (numbers of mice/genotype: n = 3 (a,e,f); n = 4 (b,c)). *p < 0.05.
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Figure 3. Expression of PLVAP in Cav1-deficient liver. (a) Immunoblot analyses of adult liver lysates (5 µg 
protein/lane) from 5 wk old wild-type, Cav1−/− and Plvap−/− mice for PLVAP and GAPDH (a house keeping 
molecule) under non-reducing conditions. Quantitative data are mean ± s.e.m. (n = 3 mice/genotype). The 
same filter was sequentially probed for PLVAP and GAPDH. Full blots are shown in Suppl. Figure  10.  
(b) Confocal microscopy analyses of PLVAP and LYVE-1 expression in the midlobular area of 5 wk old wild-
type and Cav1−/− mice and quantification of the PLVAP+ area (mean ± s.e.m, each dot represents one mouse). 
Bars, 10 µm. (c) Analyses of PLVAP expression in 24 wk old wild-type mice. Bars, 10 µm. (d) Quantitative PCR 
analyses of Lyve-1 and Plvap mRNA expression in sorted sinusoidal ECs (CD45−Podoplanin−LYVE-1+CD144+ 
cells) and non-sinusoidal (CD45−Podoplanin−LYVE-1−CD144+) EC and leukocytes (control cells) (n = 5 mice 
for both cell types). β-actin was used as a control gene. Shown are representative images (numbers of mice/
genotype: n = 3(a), n = 4–6 (b), n = 1 (c).
7Scientific RepoRtS |         (2019) 9:15698  | https://doi.org/10.1038/s41598-019-52068-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
pores, the fenestrations were morphologically similar in Plvap−/− and wild-type mice (Fig. 5b). The sinusoids 
in Plvap−/− mice looked morphologically grossly normal (single EC layer, typical intracellular organelles, intact 
inter-endothelial junctions, no basement membrane) also in all TEM analyses. The only exception was a small 
reduction in the width of space of Disse in Plvap−/− mice (Suppl. Figure 5a).
We then studied the general sinusoidal architecture in the adult liver in the absence of PLVAP. 
Immunofluorescence analyses of liver sections revealed apparently similar sinusoidal architecture and sinusoidal 
LYVE-1 (a marker for sinusoidal and lymphatic vessels) and CD31 (a pan-EC marker) expression in the adult 
wild-type and Plvap−/− mice (Suppl. Figure 5b–e). Quantifications verified the similar CD31-positive EC area in 
both genotypes (Suppl. Figure 5b). Additional quantitative flow cytometric analyses showed that the percentages 
of both LYVE-1+CD144+ sinusoidal ECs and LYVE-1−CD144+ large vessel EC were comparable in the adult 
livers of wild-type and Plvap−/− mice (Fig. 5c, Suppl. Figure 5f). Moreover, 3D-analyses of E14.5 livers, amenable 
to whole-mount imaging after optical clearing, showed similar sinusoid diameters and LYVE-1+ vascular area 
in actively angiogenic livers of wild-type and Plvap−/− mice (Fig. 5d–f and Suppl. Video 1). In scanning electron 
microscopy analyses of non-perfused E17.5 embryos putative open fenestrations were found in vessels of both 
genotypes (Suppl. Figure 5g). Collectively these data show that PLVAP protein or diaphragms at any developmen-
tal stage are not necessary for the formation of fenestrations or for the normal sinusoidal angiogenesis in the liver.
Altered scavenging of immunocomplexes in the liver of Plvap−/− mice. We studied if the genetic 
absence of PLVAP could lead to alterations in endocytosis, which is one of the characteristic functions of LSEC. 
We administered fluorescent beads (20 nm and 0.5 µm), acetylated LDL or ovalbumin (OVA)-anti-OVA antibody 
immunocomplexes (OVA-IC) intravenously to wild-type and Plvap−/− mice. Using microscopy we found that 
all four ligands were bound/taken up by both LYVE1+ cells (presumably LSEC) and F4/80+ cells (presumably 
Kupffer cells and other macrophages) in the liver in both wild-type and Plvap−/− mice (Suppl. Figure 6). Since 
cell type identification benefits from the use of multiple markers, and since intimate contacts between LSEC and 
intravascular Kupffer cells make it difficult to quantify signals separately from these two cell types, we chose to 
analyze the up-take of OVA-IC in more detail by processing livers from the in vivo OVA-IC-treated mice for flow 
cytometric analyses. In line with our previous observations18 we found a strong reduction in the numbers of 
Figure 4. Cell-surface expression of PLVAP in adult LSEC in the absence of diaphragms. (a) Confocal 
microscopy analyses of LSEC in 5 wk old wild-type and Plvap−/− mice 10 min after an intravenous bolus of 
the anti-PLVAP antibody (MECA-32). LYVE-1 was stained ex vivo. Bars, 50 µm (main figures), 10 µm (insets). 
(b,c) Immuno-electron micrographs of MECA-32 (b) and rat IgG2a isotype control antibody (c) stained 
liver sections after detection with an anti-rat immunoglobulin conjugated to 10 nm gold particles. Higher 
magnifications of the boxed areas are shown in the insets. E, sinusoidal endothelial cell; SD, space of Disse. 
Green arrowheads point to gold particles. Bars, 40 nm. Shown are representative images (numbers of mice/
genotype: n = 3 (a, wild-type), n = 1 (a, Plvap−/−), n = 3 (b,c)).
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Figure 5. Absence of PLVAP does not affect fenestral formation or liver angiogenesis but alters 
immunocomplex binding to LSEC. (a) Scanning electron micrographs of sinusoidal vessels in 5 wk old wild-
type and Plvap−/− mice. Bars, 1 µm. (b) Quantification (mean ± s.e.m., n = 9, 3 field/mouse, 3 mice/genotype) 
of the number of fenestral openings per sieve plate, the number of sieve plates per endothelial surface area, the 
number of fenestrations per endothelial cell area and the average surface area of a fenestral opening. (c) Flow 
cytometric analysis of liver EC (LYVE-1+CD144+ LSEC) and their quantification per CD45− parenchymal 
cells (left) and LYVE-1−CD144+ non-sinusoidal ECs per CD45− parenchymal cells (right)) in 5 wk old wild-
type and Plvap−/− mice. Quantitative data are mean ± s.e.m. (n = 3–4 mice/genotype). (d) Maximal z-stack 
projections (48 µm) of whole-mount stainings of E14.5 liver from wild-type and Plvap−/− mice for LYVE-1 
and PLVAP. Bars, 50 µm. (e), Quantification of sinusoidal vessel diameters in wild-type and Plvap−/− mice 
(mean ± s.e.m, 30 vessels/genotype, 2 mice/genotype). (f) Quantification of LYVE-1 and PLVAP signal areas 
from single optical sections (mean ± s.e.m, 10 vessels/genotype, 2 mice/genotype). (g–i) Flow cytometric 
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CD45+CD11blowF4/80high Kupffer cells, and possibly a slight increase in the numbers of other liver-resident mac-
rophages (CD45+CD11bhighF4/80intermediate) in the absence of PLVAP (Suppl Fig. 7a,b). In wild-type mice about 
40% of both macrophage types bound OVA-IC. The remaining Kupffer cells, but not the dominant non-Kupffer 
macrophages, showed significantly reduced OVA-IC scavenging in Plvap−/− mice (Suppl. Figure 7c–e). When 
focusing on endothelial scavenging function, the FACS analyses showed that practically 100% of LSEC in the 
wild-type mice had efficiently bound or taken up OVA-IC (Fig. 5g). In Plvap−/− mice the amount of OVA-IC 
ingested per LSEC was significantly reduced (Fig. 5h,i). It should be noted that administration of the same 
amount of OVA-IC to wild-type and Plvap−/− mice results in some uncertainty regarding the availability of the 
OVA-IC to LSEC due to different macrophage numbers, altered blood composition, and organ size in the absence 
of PLVAP. Similar to the other reported Plvap−/− lines8,9, our Plvap−/− mice show modest reduction of blood 
erythrocytes in the presence of unaltered numbers of other blood cell types, hyperlipemia and reduced concen-
tration of blood proteins smaller than 70 kDa (Suppl. Figure 8a–c). Our Plvap−/− mice or their livers were not 
severely growth retarded, and their liver/body weight ratio was actually somewhat increased when compared to 
littermate controls (Suppl. Figure 8d–e). It is possible that genetic absence of PLVAP in the EC and/or the sec-
ondary effects of vascular barrier defects may alter the transcriptome of PLVAP-deficient EC (e.g. by affecting the 
expression of Fc- or scavenging receptors or endocytic machinery) and thereby lead to altered binding of immu-
nocomplexes. Therefore, the presence of confounding factors needs to be taken into account when interpretating 
these scavenging data.
PLVAP associates with different molecules in fetal and adult LSEC. In addition to homodimeric 
interactions necessary for diaphragm formation6, PLVAP may associate with other molecules in EC. To evaluate 
this, we used proximal ligation assays, which gives a positive signal if the two molecules associate (i.e. are less than 
40 nm apart from each other46). We noticed that although both fetal and adult liver express PLVAP and LYVE-1, 
a PLA signal between the two molecules was only detectable in the fetal LSEC (Fig. 6a).
The possible molecular association between neuropilin-1 and PLVAP, which has been previously described 
in an adult non-hepatic diaphragmed vasculature47, was then studied. In wild-type mice we observed a clear 
expression of neuropilin-1 in E14.5 LSEC (Suppl. Figure 9a), and its association with PLVAP (Fig. 6b). In the 
adult wild-type LSEC, both PLVAP and neuropilin-1 (Suppl. Figure 9b) were still present, but the PLA signal 
was completely lost (Fig. 6b). The expression of neuropilin-1was not dependent on the association with PLVAP, 
since the distribution of neuropilin-1 was unaltered in fetal and adult LSEC in Plvap−/− mice (Suppl. Figure 9a,b).
Since neuropilin-1 is an important co-receptor in VEGF-driven signaling48, we also studied the association 
of PLVAP and the main VEGF receptor, VEGFR2, in the liver sinusoids. We found a novel molecular association 
between PLVAP and VEGFR2 in the fetal LSEC (Fig. 6c). The association between the two molecules was not 
detectable in adult LSEC (Fig. 6c), although VEGFR2 was still present in the adult sinusoids (Suppl. Figure 9c). In 
fact, the association of neuropilin-1 and VEGFR2 seemed to display a similar developmental regulation, since it 
was seen mainly in the fetal liver (Fig. 6d). Collectively these data suggest that in the fetal LSEC PLVAP is engaged 
both in homodimeric interactions necessary for the formation of diaphragms6, and in molecular associations 
with the critical surface components of the VEGFR2-angiogenic signaling pathway. Concomitantly with the dis-
appearance of PLVAP diaphragms at birth, PLVAP molecules on the LSEC membrane become molecularly sep-
arated from neuropilin-1 and VEGFR2 (and from Lyve-1), and the neuropilin-1-VEGFR2 complex dissociates.
Discussion
Here we show that during the fetal development LSEC contain fenestrations covered with diaphragms, which are 
formed by PLVAP protein. Despite the disappearance of the diaphragms in LSEC, but not in vein ECs, at birth, 
LSEC continue to express PLVAP on the membrane in the adulthood. This is striking, since so far PLVAP has 
been thought to reside exclusively in the diaphragms6,8. Genetic absence of PLVAP, and hence of the fetal fenestral 
diaphragms, did not affect the generation of fenestrations or the vascular architecture in the liver. We also found 
novel associations between PLVAP and LYVE-1, neuropilin-1 and VEGFR2 in fetal LSEC.
The biogenesis of LSEC fenestrae remains poorly understood31–33. Typically 6–8% of LSEC surface area is 
constituted by fenestrae, and their numbers and membrane localization are altered within minutes49,50. Fenestral 
formation has been proposed to be orchestrated by fenestra-forming centers, which regulate the concentration 
of an acto-myosin ring around the new fenestrae and possibly promote depletion of intracellular organelles from 
the pore area31–33. Notably, the generation of fenestrae in liver has been proposed to be PLVAP-dependent24. Using 
a different PLVAP-deficient mouse line, Herrnberger et al. found a more than 6-fold reduction in the numbers 
of fenestrations and the absence of sieve plates in livers of 3 wk old Plvap−/− mice. In those knock-outs, adult 
livers had a scarred surface, sinusoid lumens containing fibrin aggregates, a practically missing Disse’s space filled 
with collagen bundles, and hepatocytes full of lipid granules24. Moreover, severe hepatic ballooning, steatosis, 
leukocyte infiltration, focal necrosis and fibrosis were observed24. None of these alterations, which are signs of 
liver injury, is found in our Plvap−/− mice. Therefore, we hypothesize that the diminished fenestrae observed in 
the Hernnberger-strain may be secondary due to LSEC capillarization, which is a prototypic reactive response 
analyses of LSEC (Live+CD45−LYVE-1+CD144+ cells) 2 h after an intravenous injection of Atto-488 conjugated 
OVA-IC in 5 wk old wild-type and Plvap−/− mice. (g) The percentage of LSEC (from all LSEC) that have taken 
up OVA-IC (mean ± s.e.m, 3–4 mice/genotype). (h) Representative histograms of the distribution of Atto-488-
labeled OVA-IC in LSEC. Control, a mouse to which vehicle only (PBS) is administered. i Quantification of the 
mean fluorescence intensities (MFI) from (g). Representative images are from (n = 3 mice/genotype (a), and 
n = 2 mice/genotype (d) and 3–4 mice/genotype (h). *p < 0.05, ***p < 0.001.
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Figure 6. PLVAP associates with LYVE-1, neuropilin-1 and VEGFR2 in fetal but not adult LSEC.  
(a–d) Proximal ligation analyses (PLA) of the associations between PLVAP and LYVE-1 (a), PLVAP and 
neuropilin-1 (Nrp1) (b), PLVAP and VEGFR2 (c) and VEGFR2 and Nrp1 (d) in fetal and adult livers. The white 
signals show associations between the indicated molecules, and the green stainings show expression of PLVAP 
(a–c) and VEGFR2 and Nrp1 (d). The boxed areas are shown at a higher magnification in the insets. Red arrows 
point to representative PLA signals. Bars, 10 µm. The quantifications (the area fraction of the white signal per 
PLVAP (a–c) or Nrp1 + VEGFR2 (d) positive sinusoids) are shown (mean ± s.e.m., n = 2–5 fields/mouse, 3–4 
mice/genotype). *p < 0.05.
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to almost any type of liver injury33,39,51. Since the constructs used by Herrnberger and us are relatively similar 
(IRES:lacZ trapping cassette between exons 1 and 2 in the Herrnberger and loxP sites flanking the proximal 
promoter and in the first intron after the exon 1 in ours), the differences in the mouse strains (C57BL6N/FVB-N 
hybrid in the Herrnberger-strain and C57BL6N/Balb/c/NMRI hybrid in ours) may contribute to these discrepant 
results. In addition, the interaction of environmental factors (microbiota, food etc) with altered vascular permea-
bility and leukocyte traffic8,18 induced by PLVAP-deletion may contribute to triggering of liver injury in some col-
onies. Although not directly analyzed in the third independent Plvap−/− strain, Stan et al. do not refer to any liver 
injury or lack or fenestration in their mouse strain either8. Collectively these data indicate to us that the fenestral 
formation in liver is not dependent on PLVAP gene itself. Our findings in liver are in line with the observations 
that fenestral formation in other organs is PLVAP-independent8.
In addition to angiogenesis, VEGF signaling is involved in the formation of fenestrae. Trapping of hepatic 
VEGF diminishes fenestral formation in liver, and administration of exogenous VEGF enhances fenes-
tral formation at least in non-hepatic vasculature52,53. We found that neuropilin-1, an accessory molecule 
enhancing VEGF signaling48, and the major VEGF receptor VEGFR2 are associated with PLVAP in fetal 
liver with diaphragmed fenestrae, but not in the adult LSEC with open fenestrae. Nevertheless, association of 
VEGFR2-neuropilin-1 complex with PLVAP was not necessary for the hepatic angiogenesis or fenestration, 
since both processes were normal in PLVAP-deficient mice. However, our findings clearly indicate that in addi-
tion to well-established homodimer formation in diaphragms6, PLVAP protein is capable of associating with 
several other surface molecules.
We found here that fenestrae in LSEC are distended by a diaphragm during the fetal development, and that 
the diaphragms then quite abruptly disappear at birth in mice. In rats electron microscopy studies well before the 
discovery of PLVAP have also reported the presence of diaphragms in fetal sinusoids in rat36,37, and those have 
also being reported in the wild-type littermate controls in the Herrnberger mouse strain24. The functional roles of 
diaphragmed fenestrae during the ontogeny are not fully understood. We have seen that the PLVAP-diaphragms 
regulate the exit of fetal-liver derived monocytes to blood, and thereby the seeding of fetal-derived macrophages 
in tissues18. Here we show that in fetal liver PLVAP associates with LYVE-1, VEGFR2 and neuropilin-1, sug-
gesting that the fenestral diaphragms might regulate the localization of different supramolecular complexes 
during the development. In addition, the diaphragms in fetal liver sinusoids presumably restrict the movement 
of blood-borne molecules to the space of Disse by serving as a physicochemical filter. The signals triggering 
redistribution of PLVAP in LSEC at birth remain to be determined. However, they need to be quite selective 
since PLVAP-diaphragms distending caveolae, fenestrations and transendothelial channels were still observed in 
postnatal vein EC.
PLVAP has been used for decades as the golden standard marker for blood vessels4,6,54. The protein has 
thought to be present only in diaphragms, which can cover fenestrae, transendothelial channels and caveolae6,7,55. 
Therefore, PLVAP expression has been interpreted to serve as a surrogate marker for these specific nanoscale 
structures, which can only be detected by electron microscopy. This assumption correlates well with the fact that 
high PLVAP expression is seen in capillaries known to be rich in these structures (e.g. intestine, endocrine organs, 
choroid plexus), whereas non-leaky capillaries in the heart and brain parenchyma, and non-diaphragmed fenes-
trated capillaries in the glomeruli are devoid of PLVAP6,7. However, there has been considerable discrepancy in 
the literature regarding the expression of PLVAP in adult liver8,19–24. Our results, utilizing a validated monoclonal 
anti-PLVAP antibody and Plvap−/− mice as a specificity control, now clearly show that in adult liver PLVAP is 
strongly expressed in the venular EC (portal and central vein), clearly expressed in sinusoidal EC and absent from 
the hepatic artery EC. The sinusoidal PLVAP expression reveals a novel subcellular localization of PLVAP outside 
the diaphragms. Moreover, our findings of similar PLVAP expression in LSEC in wild-type and Cav-1-deficient 
mice contradict the assumption that PLVAP would undergo rapid internalization and degradation in the absence 
of diaphragm-forming structures55.
There are limitations in our study. Plvap−/− mice have major alterations in vascular permeability and its 
consequences (e.g. metabolic alterations, growth retardation) may result in secondary transcriptomic and 
metabolomic changes that are not directly controllable when using littermate control mice. For instance, the 
determinants affecting non-specific binding of MECA-32 antibody or in vivo intravascular availability of 
OVA-IC may be different between Plvap−/− mice and their controls. Moreover, the spatial resolution of the 
imaging techniques used here is unable to provide definite proof for the luminal localization of PLVAP on the 
EC membrane outside the diaphragms, for the detailed vascular architecture or for the possible complex for-
mation between PLVAP and LYVE-1, neuropilin and VEGFR2. Since in situ perfusion-fixation of embryonic 
liver is impossible due to ethical limitations, detailed analyses of fenestral diaphragms in embryonic LSEC 
by scanning or immunoelectron microscopy was not possible. However, it would be interesting to dissect the 
prevalence, grouping and dynamics of diaphragmed/non-diaphragmed fenestrae during physiological sieve 
plate formation in embryos in a future project. Nevertheless, in aggregate our current multimodal imaging 
data suggest that there are no apparent differences in the formation of liver vasculature or fenestrations in 
Plvap−/− mice either during embryogenesis or after birth. Finally, the ambiguity regarding the expression of 
the prototypic leukocyte marker CD45 in LSEC.33,56, makes it possible that a subpopulation of LSEC may have 
been excluded when gating for CD45− cells.
In conclusion, we have shown here using multimodal approaches that fetal liver LSEC contain fenestrae 
covered by PLVAP-diaphragms and that PLVAP can be engaged in novel associations with LYVE-1, VEGFR2 
and neuropilin-1 in the developing liver. In contrast, adult LSEC lack diaphragms in fenestrae, but still contain 
cell-surface expressed PLVAP. These findings critically alter the prevailing concepts that PLVAP would only be 
present in diaphragms and that it would be needed for fenestral biogenesis in the liver.
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Methods
Experimental animals. Universally and constitutively PLVAP-deficient (Plvaptm1Salm; hereafter designated 
Plvap−/−) mice and their littermate wild-type controls have been described14. Cav1−/− (004585) and C57BL/6 J 
(000664) mice were from The Jackson Laboratory. Wild-type C57BL/6 N and BALB/c mice were from Charles 
River and Janvier Labs. In timed matings the day of vaginal plug appearance was considered as embryonic 
day 0.5 (E0.5). Postnatal analyses of Plvap−/− mice was limited to 5 wk, since only few mice survive till early 
adulthood8,9,14.
All animal experiments were done in adherence with the rules and regulations of the Finnish Act on Animal 
Experimentation (62/2006) and were performed according to the 3R-principle. The experiments were approved 
by the Ethical Committee for Animal Experimentation in Finland (license numbers 5587/04.10.07/2014 and 
6211/04.10.07/2017).
Immunofluorescence stainings and image analysis. Livers were excised from euthanized mice and 
immediately cut to small pieces. The pieces were embedded in optimal cutting temperature compound (OCT; 
Tissue-Tek, #4583) and snap frozen using liquid nitrogen. Cryostat sections (6 μm in thickness) were cut with 
cryomicrotome (Leica) and fixed in ice-cold acetone.
For immunofluorescence stainings the following antibodies were used: rat anti-PLVAP primary antibody 
MECA-32 (BD, #550563 or BioXCell, #BE0200) detected with Alexa Fluor 488- or Alexa Fluor 647-conjugated 
anti-rat IgG secondary antibody (Life Technologies, #A-11006 and #A-21247, respectively), rabbit anti-LYVE-1 
primary antibody (ReliaTech, #103-PA50) detected with Alexa Fluor 546-conjugated anti-rabbit IgG secondary 
antibody (Life Technologies, #A-11035), goat anti-neuropilin-1 primary antibody (R&D, #AF566) detected with 
Alexa Fluor 647–conjugated anti-goat IgG secondary antibody (Life Technologies, #A-21447), goat anti-VEGFR2 
primary antibody (R&D, #AF644-SP) detected with Alexa Fluor 647–conjugated anti-goat IgG secondary anti-
body, APC-conjugated anti-CD31 antibody (Biolegend, #102510), Alexa Fluor 647-conjugated anti-CD144 anti-
body (BD, #562242) and rat anti-F4/80 primary antibody (BioRad, #MCA497GA) detected with Alexa Fluor 
488- or 546-conjugated anti-rat IgG secondary antibodies (Life Technologies, #A11006 and #A11081, respec-
tively). As a negative control for MECA-32, rat isotype control IgG2a (BD, #553926) was used. All primary and 
directly conjugated antibodies were diluted at predetermined optimal concentrations (5–10 μg/ml) in phosphate 
buffered saline (PBS; Gibco, #18912-014 or Sigma, #D8537). Secondary antibodies were diluted in PBS supple-
mented with 5% normal mouse serum (Jackson ImmunoResearch, #015-000-120). The sections were sequentially 
incubated with the indicated antibodies for 30 minutes at room temperature in a humidified chamber after which 
they were washed two times with PBS. Finally, the sections were mounted in ProLong Gold Antifade Mountant 
with or without DAPI (4,6-diaminodino-2-phenylindole; ThermoFisher Scientific, #P36931 or #P36930) or the 
nuclei were stained with Hoechst (diluted 1:5000 in PBS; ThermoFisher Scientific, #62249) for 5 minutes and then 
mounted with ProLong Gold without DAPI.
For the whole-mount stainings, the fetal livers were stained and optically cleared as described35.
Images were acquired using LSM 780 or LSM 880 confocal microscope with Airyscan (Carl Zeiss) equipped 
with c-Apochromat 40x/1.20 water objective or c-Apochromat 63x/1.20 and ZEN software or 3i Spinning disk 
confocal microscope equipped with a LD c-apochromat 40x/1.1 water objective and SlideBook 6 software 
(Intelligent Imaging Innovations).
For image analyses, background subtractions, linear brightness adjustments, and, if used, noise reductions 
using mean filter in ImageJ, were always applied equally to all images that were compared. Three–dimensional 
reconstructions were generated from z-stacks (wild-type: 60 slices, 0.8 μm/slice and Plvap−/−: 112 slices, 0.43 μm/
slice) and the results were converted to QuickTime files with Imaris 8.0 software (Bitplane).
For the quantifications, mean gray values for MECA32 signal were measured from original 8-bit or 16-bit 
images using thresholded selection in the chosen areas (see Suppl. Figure 2d) using imageJ. A thresholded selec-
tion from the original image was created by first subtracting heavily Gaussian blurred background image and 
then applying the default thresholding method. MECA32 and CD31 signals were used for thresholding the portal 
vein, the three sinusoidal segments and central vein (Fig. 2d) and hepatic artery and portal vein (excluding the 
luminal areas; Suppl. Figure 2c and d). Resulting data was normalized to the value obtained from portal vein. Area 
of signal was measured from thresholded images in imageJ. Background subtraction with rolling ball method or 
subtracting heavily Gaussian blurred image and median filtering for noise reduction were performed prior to 
thresholding with Li (Fig. 3b), Otsu or Moments (LYVE-1 and MECA32 signals, respectively, Fig. 5f) methods. 
All steps were performed in the same way for all images that were compared with each other. Vessel diameters 
were determined from randomly picked LYVE-1+ vessels (30 vessels/genotype, 2 mice/genotype) using Image J 
analyses of X-Y plains of whole-mount stacks.
Histological stainings. For hematoxylin and eosin stainings acetone-fixed cryostat sections of livers from 
wild-type mice were first rehydrated in H2O, then stained in Mayer’s Hematoxylin (Sigma, #MHS16) for 15 min-
utes and washed in warm tap water for 10 min. Next, the sections were dehydrated in 96% ethanol for 30 s and 
then stained in Eosin Y solution (Sigma Aldrich, #HT110116) for 3 min after which the excess eosin was removed 
by dipping the sections in absolute ethanol. Lastly, the sections were cleared in xylene (2 × 5 minutes; VWR 
Chemicals, #28973.363) and mounted with DPX Mountant (Sigma, #06522). The sections were imaged with 
Pannoramic MIDI digital slide scanner (3D Histech).
Transmission and scanning electron microscopy and electron tomography. Transmission elec-
tron microscopy was performed as previously described18, except that euthanized adult mice were perfusion-fixed 
with 2% glutaraldehyde and 4% paraformaldehyde before the immersion fixation.
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Electron tomography was performed on 150 nm sections (prepared as described above) using 15 nm gold nan-
oparticles deposited on both surfaces as fiducial markers. JEM-1400 Plus operated at 120 kV was used to collect 
dual-axis tilt series from −65° to + 65° with 1.5° steps using SerialEM version 3.3.157 Tomograms were generated 
and visualized using the IMOD software package version 4.7.358. Tomograms were filtered by the nonlinear ani-
sotropic diffusion filter of the IMOD package.
For scanning electron microscopy tissue pieces were immersion-fixed in a phosphate buffer containing 2% 
glutaraldehyde and 4% paraformaldehyde (adult, but not embryonic, mice were first perfusion-fixed with the 
same buffer). The tissue pieces were then post-fixed for 2 h using 2% OsO4 containing 3% potassium ferrocya-
nide, dehydrated with a series of increasing ethanol concentrations (30%, 50%, 70%, 80%, 90%, 96% and twice 
100%). Tissue pieces were then frozen by immersion in liquid nitrogen and manually fractured under liquid 
nitrogen59. The fractured pieces were immersed in hexamethyldisilazane and left to dry by solvent evaporation. 
Tissue pieces were coated by evaporated gold and imaged with Leo 1530 Gemini scanning electron microscope. 
The sieve plates and fenestral openings were manually defined from the SEM-images, and the surface areas of 
vessels and individual pore openings were determined using Image J.
Immunoelectron microscopy. Mice were sacrificed with CO2 and transcardially perfused with 37 °C 
PBS, followed with perfusion of PLP-fixative containing 0.2% glutaraldehyde. Livers were collected and 
immersion-fixed in the same buffer for 1 h in room temperature. Samples were cryoprotected with 2.1 M sucrose 
in water at 4 °C overnight, embedded in OCT and snap-frozen with liquid nitrogen. 10 µm sections were cut, 
washed once with 0.1 M NaPO4, pH 7.4., and blocked in the same buffer containing 1% fish gelatin (Sigma # 
G-7765) and 1% bovine serum albumin for 30 min at room temperature. Thereafter, MECA-32 and isotype con-
trol antibodies (100 µg/ml) diluted in the washing buffer containing 0.5% fish gelatin and 0.5% bovine serum 
albumin were incubated on the sections at 4 °C overnight. After washings, 10 nm gold-conjugated anti-rat IgG 
(BBI Solutions, #EM.GAT10, 1:50 dilution) in the antibody dilution buffer was incubated on the sections at room 
temperature for 3 h. After washing with 0.1 M NaPO4, the sections were post-fixed with 2% glutaraldehyde in 
0.1 M NaPO4 for 30 min at room temperature and washed again. The immunolabelled sections were post-fixed 
with 1% osmium tetroxide in 0.1 M NaPO4 buffer, pH 7.4, for 1 h at room temperature, washed twice, dehydrated 
through series of increased concentration of ethanol and acetone and gradually infiltrated into Epon resin (TAAB, 
Aldermaston, United Kingdom). After resin polymerization at 60 °C, 60-nm sections were cut (EM Ultracut UC6i 
ultramicrotome, Leica Mikrosysteme GmbH, Austria) and post-stained with uranyl acetate and lead citrate.
Detection of cell-surface PLVAP. For confocal analyses, 10 µg of MECA-32 was intravenously injected 
to tail vein of 4 wk old wild-type and Plvap−/− mice. After 10 min, mice were sacrificed using CO2 and livers 
were collected, cut to small pieces, embedded in OCT and snap frozen using liquid nitrogen. Acetone-fixed 
frozen sections were then stained ex vivo with anti-rat IgG-A647 (to detect in vivo bound MECA-32) followed 
by rabbit anti-mouse LYVE-1 and A546-conjugated anti-rabbit IgG secondary antibody. In control stainings the 
second-stage antibodies were confirmed to be completely species-specific.
For electron microscopy analyses, MECA-32 antibody was directly conjugated to 10 nm gold nanoparticles 
using GOLD conjugation kit (Abcam, #201808), and the buffer was changed to PBS. Conjugated MECA-32 (5 µg) 
was intravenously injected to a C57Bl/6 N wild- type female mouse. After 10 min circulation time, the mouse 
was sacrificed with CO2 and perfusion-fixed by transcardial perfusion of 0.2 M phosphate buffer containing 4% 
paraformaldehyde and 2% glutaraldehyde. Thereafter, the liver was collected and processed as described above 
for transmission electron microscopy.
Immunoblottings. Immunoblotting was performed as previously described18. In brief, at autopsy, whole 
livers were dissected from wild-type, Plvap−/− and Cav1−/− mice, chopped into small tissue fragments mechan-
ically using scissors, and lysed for 1 h at 4 °C in a buffer containing 0.2% NP-40, 150 mM NaCl, 1.5 mM MgCl2, 
10 mM Tris, pH 7.2, and Roche Protease Inhibitor Cocktail. After clarification by centrifugation, the protein 
concentrations were measured using Bio-Rad DC kit from the lysate supernatants. Aliquots of lysates were mixed 
with non-reduced Laemmli’s sample buffer and heated to 37 °C for 10 min. The samples were then resolved in 
SDS-PAGE (5 µg protein/lane; under non-reducing conditions). After transfer to nitrocellulose, PLVAP was visu-
alized with MECA-32 using an enhanced chemiluminescence detection system (Amersham). After stripping the 
same filter was reprobed for GAPDH expression. The band quantifications were made using ImageJ. Equal ROIs 
were selected and mean grey values were calculated. Thereafter background value (an irrelevant area in image) 
was subtracted from these, and finally the PLVAP/GAPDH signal ratio was determined. The original full-size 
immunoblots are shown in Suppl. Figure 10.
In vivo scavenging assays. Particles, modified proteins and immunocomplexes were administered to 
adult Plvap−/− and control mice. As particles, 20 µl of 0.5 µm FluoSpheres carboxylate-modified microspheres 
(505/515; ThermoFisher, #F8813) and 0.02 µm FluoSpheres carboxylate-modified microspheres (660/680; 
ThermoFisher, #F8783) were used. Alexa Fluor 594-conjugated acetylated-LDL (ThermoFisher, #L35353; 10 µl/
mouse) represented modified proteins. To prepare ovalbumin (OVA)-anti-OVA antibody immunocomplexes, 
Atto488-conjugated OVA (Sigma, #41235) or Alexa Fluor 647-conjugated OVA (Q34784, Molecular probes) 
(50 µl from 2 mg/ml solution in PBS) was mixed with an rabbit polyclonal anti-OVA IgG (5.4 µl from 3.7 mg/ml 
solution, Sigma, #C6534) for 1 h at 4 oC, and 55.4 µl of the complex was then administered per mouse. All com-
pounds were injected into tail vein and allowed to circulate for 2 h before collecting the livers for microscopy 
and FACS analyses. Only mice in which the total injection volume was smoothly delivered were included in the 
analyses.
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Flow cytometry and sortings. Parenchymal liver cells in untouched or OVA-immunocomplex treated 
wild-type and Plvap−/− mice (see above) were dissociated using Gentle MACS C-tube (Miltenyi Biotech) and 
enriched using 26.6% Optiprep gradient. The cells were first stained with Fixable viability dye eFluor780 (eBiosci-
ence, #65–0866) according to the manufacturer’s instructions to discriminate dead and live cells. Next, the cells 
were incubated with purified anti-CD16/32 for 10 min on ice to block non-specific binding to Fc-receptors. The 
cells were then stained for 30 min on ice using fluorochrome-conjugated monoclonal antibodies. The endothelial 
cell panel included PerCP-Cy5.5-conjugated or V500-conjugated CD45 (BD, #550994 and 561487, respectively), 
Alexa-647-conjugated CD144 (BD, # 562242), PE-conjugated Lyve-1 (R&D Systems, FAB2125P); Alexa-488 con-
jugated MECA-32 (Biolegend, #120506) and PE-Cy7-conjugated podoplanin (Biolegend, # 127412). The mac-
rophage panel included CD45, V500-conjugated CD45 (BD, #561487), BV786-conjugated CD11b (BD, #740861) 
and Alexa Fluor 647-conjugated F4/80 (BioRad, #MCA497A647) antibodies. All FACS analyses were run using 
LSRFortessa flow cytometer (BD Biosciences) and analyzed using FlowJo (Tree Star Inc.) software.
For sortings, viable (viability dye negative) liver sinusoidal (CD45−Podoplanin−LYVE-1+CD144+) and 
non-sinusoidal (CD45− Podoplanin−LYVE-1−CD144+) vascular EC were isolated using FACS aria II (70 µm 
nozzle, Beckton-Dickinson) cell sorters. The purity of the isolated populations was >95%.
Quantitative real-time PCR. Total RNA was isolated from sorted liver EC (see above) using RNeasy Plus 
Micro Kit (QIAGEN, #74034) and reverse transcribed to cDNA with SuperScript VILO cDNA Synthesis Kit 
(ThermoFisher Scientific, #11754050) according to the manufacturers’ instructions. Quantitative PCR was car-
ried out using Taqman Gene Expression Assays (ThermoFisher Scientific) for Plvap (Mm00453379_m1; target 
gene), Lyve-1 (Mm00475056_m1; target gene) and Actb (Mm00607939_s1; control gene).
Blood and serum analyses. Cardiac blood was drawn from 5 wk old wild-type and Plvap−/− mice into 
heparinized tubes. Automated hemocytometer (VetSCan HM 5, Abaxis) was used to determine the blood eryth-
rocyte, platelet, total leukocyte, lymphocyte, neutrophil and monocyte numbers. The total protein, albumin, 
amylase and blood urea nitrogen concentrations were analyzed from the heparinized plasma using VetScan VS2 
(Abaxis).
Proximity ligation assays (PLA). To study PLVAP-nrp1, PLVAP-LYVE1, PLVAP-VEGFR2 and 
VEGFR2-nrp1 associations, proximity ligation assays (PLA) were performed46. Briefly, primary antibodies 
to VEGFR2 (R&D, #AF644-SP) and LYVE1 were detected using Duolink in situ PLA probe anti-goat PLUS 
(Sigma, #DUO92003) and PLA probe anti-rabbit PLUS (Sigma, #DUO92002), respectively. Rat anti-PLVAP 
antibody (MECA-32) and goat anti-neuropilin1 were directly conjugated to Duolink in situ PLA probe MINUS 
using Duolink in situ probemaker MINUS kit (Sigma, #DUO92010). After antibody stainings and PLA probe 
incubations, the ligation and amplifications were performed using Duolink in situ Detection kit red (Sigma, 
#DUO92008). During the amplification step, Alexa 488-conjugated donkey anti-rat IgG (Invitrogen, #A21208) 
and Alexa647-conjugated donkey anti-goat IgG (Invitrogen, #A21447) were added to detect PLVAP and neuropi-
lin1/VEGFR2, respectively. Nuclei were stained with DAPI and the slides were mounted in Mowiol. Images were 
obtained using a 3i Spinning disk confocal microscope equipped with a plan-apochromat 63x/1.4 oil objective 
and SlideBook 6 software (Intelligent Imaging Innovations) or LSM780 (Carl Zeiss) equipped with c-Apochromat 
40x/1.20 water objective and using ZEN software.
ImageJ was used for quantifications. Background was subtracted using rolling ball method for the PLA-signal 
and sinusoidal signal (sinusoids identified by MECA-32-positivity or with nrp1/ VEGFR2-positivity, as appropri-
ate). Sinusoidal ROI area was generated by thresholding the sinusoidal signal. After applying ROIs to thresholded 
PLA-signal, % of area was measured and quantified from 3–5 images/mouse (63x objective) and 2 images/mouse 
(40x objective), respectively. All adjustments were applied equally for the samples that were compared.
Statistical analysis. Comparisons between genotypes or treatments were done with Mann-Whitney U-test 
using Graphpad Prism 7 or SAS version 9.4 software. All quantitative data are given as mean ± sem. P values of 
<0.05 were considered to be statistically significant.
Data availability
All materials are available commercially or from the authors. All data generated or analysed during this study are 
included in this published article (and its Supplementary Information files).
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